<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta name=Title content="Table 1">
<meta name=Keywords content="">
<meta http-equiv=Content-Type content="text/html; charset=macintosh">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="Table1_references_files/filelist.xml">
<title>Table 1</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Pauline</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Pauline</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:LastPrinted>2001-07-26T03:04:00Z</o:LastPrinted>
  <o:Created>2001-08-10T18:40:00Z</o:Created>
  <o:LastSaved>2001-08-10T18:40:00Z</o:LastSaved>
  <o:Pages>6</o:Pages>
  <o:Words>1371</o:Words>
  <o:Characters>7818</o:Characters>
  <o:Lines>65</o:Lines>
  <o:Paragraphs>15</o:Paragraphs>
  <o:CharactersWithSpaces>9601</o:CharactersWithSpaces>
  <o:Version>9.2511</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Times New Roman";
	panose-1:0 2 2 6 3 5 4 5 2 3;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:50331648 0 0 0 1 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Times;}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:12.0pt;
	font-family:Times;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:12.0pt;
	font-family:Times;
	text-decoration:underline;
	text-underline:single;}
span.MsoEndnoteReference
	{vertical-align:super;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Times;}
 /* Page Definitions */
@page
	{mso-endnote-numbering-style:arabic;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
</head>

<body bgcolor=white lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<p class=MsoNormal>References for Table 1.<span style="mso-spacerun:
yes">&nbsp; </span>Proteins with substitutions that have been shown to be
involved in disease.<span style="mso-spacerun: yes">&nbsp; </span><b>In bold
are the substitutions for which there is evidence supporting the
prediction.<span style="mso-spacerun: yes">&nbsp; </span></b><span
style='font-weight:normal'>The first column is the substitution, the second
column is the SIFT prediction, the third column are the references for the
variant.</span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;
 border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr>
  <td width="100%" colspan=3 valign=top style='width:100.0%;border:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p>
  <p class=MsoNormal><b>Protein: Fibrillin</b><span style='font-weight:normal'>
  </span></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>S1077P</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Tolerated</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Liu, et al. 1997/1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>D1113G<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <h1>Damaging</h1>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Liu, et al. 1997/1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>P1148A<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Tolerated<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Polymorphism (Liu, et al. 1997/1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>C1153Y<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>In MFS (according to SWISS-PROT)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>V1667I</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Tolerated</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Liu, et al. 1997/1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>N1341S</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Tolerated</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Liu, et al. 1997/1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>N1282S</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Tolerated</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Liu, et al. 1997/1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>V2018I<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <h1>Tolerated</h1>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Control (Pima Indian) (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>I2023T<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Liu, et al. 1997/1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>C2038Y<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>C2053F<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>C2500S<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>G2514R<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>C2110R<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Y2113F<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Tolerated<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Control (Pygmy) (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>C2170F<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Marfan (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>D2329E<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Tolerated<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Control (Taiwan) (Peter Oefner, personal communication)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>P2278S<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Tolerated<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Control (Sudan, Pakistan) (Peter Oefner, personal
  communication)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;
 border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr>
  <td width="100%" colspan=3 valign=top style='width:100.0%;border:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p>
  <p class=MsoNormal><b>Protein: </b><span style='font-family:Symbol'><b>a</b></span><b>-melanocyte
  stimulating hormone receptor <o:p></o:p></b></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>R151C<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <h1>Damaging</h1>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Increased risk of CMM (Palmer, et al. 1999)</p>
  <p class=MsoNormal>Also shown to be unable to produce cAMP upon stimulation
  (Frandberg, et al. 1998).<span style="mso-spacerun: yes">&nbsp; </span></p>
  </td>
 </tr>
 <tr style='height:43.15pt'>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:43.15pt'>
  <p class=MsoNormal>D84E</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:43.15pt'>
  <p class=MsoNormal>Damaging</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:43.15pt'>
  <p class=MsoNormal>Risk of melanoma (Valverde, et al. 1996) but then later
  found to not be associated with CMM.(Healy, et al. 1999, Palmer, et al. 1999)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>R163Q<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <h1>Tolerated</h1>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Detected from comparison of mRNA sequences (Irizarry, et
  al. 2000) and sequencing projects (TSC-CSHL). </p>
  <p class=MsoNormal>No association with CMM (Box, et al. 2001)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>L60V<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Tolerated<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>No association with CMM (Palmer, et al. 1999 and Box, et
  al. 2001)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>R160W<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Double risk of CMM (Palmer, et al. 1999)</p>
  </td>
 </tr>
 <tr style='height:13.9pt'>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;
  height:13.9pt'>
  <p class=MsoNormal><b>D294H<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.9pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.9pt'>
  <p class=MsoNormal>Double risk of CMM (Palmer, et al. 1999)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;
 border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style='height:30.55pt'>
  <td width="100%" colspan=3 valign=top style='width:100.0%;border:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:30.55pt'>
  <p class=MsoNormal><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p>
  <p class=MsoNormal><b>Protein: Peroxisome proliferator activated receptor </b><span
  style='font-family:Symbol'><b>a</b></span><b><o:p></o:p></b></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>R127Q<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <h1>Damaging</h1>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Found in diabetics (Au, et al. 1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>L162V<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Found in diabetics and control (Au, et al), but increases
  cholesterol and apolipoprotein B levels in diabetics, and perhaps
  nondiabetics (Flavell, et al. 2000, Lacquemant, et al. 2000, Vohl, et al.
  2000).</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>V227A<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Tolerated<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoEndnoteText>Detected in diabetics (Au, et al., 1998) but found in
  similar frequencies between diabetics and nondiabetics in another study
  (Hara, et al. 2001)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>A268V<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Tolerated<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Detected in diabetics (Au et al., 1998) and comparison of
  mRNA sequences: L02932 and NM_005036(derived from L02932) (Irizarry, et al.
  2000) </p>
  <p class=MsoNormal>No association with diabetes or coronary heart disease
  (Lacquemant, 2000)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>D304N<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Detected in diabetics (Au, et al., 1998)</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>R409T<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Detected in diabetics (Au, et al., 1998)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;
 border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr>
  <td width="100%" colspan=3 valign=top style='width:100.0%;border:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Protein: 5,10-methylenetetrahydrofolate reductase,
  possible case of balancing selection<o:p></o:p></b></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoEndnoteText>R68Q</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Damaging</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Submitted by University of Washington Genome Center</p>
  <p class=MsoNormal>??? Role unknown. </p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <h1>A222V</h1>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <h1>Damaging</h1>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoEndnoteText>Diminished enzyme activity shown and increased risk
  of vascular disease and neural tube defects (Frosst, et al. 1995) BUT reduced
  risk of adult acute leukemia (Skibola,et al. 1999), childhood leukemia
  (Wiemels, et al. 2001), and colon cancer (Ma, et al. 1997) </p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>E429A<o:p></o:p></b></p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b>Damaging<o:p></o:p></b></p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Diminished enyme activity (Weisberg, et al. 1998)</p>
  <p class=MsoNormal>Reduction in risk to acute leukemia (Skibola, et al. 1999)</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=1 cellspacing=0 cellpadding=0 width="100%" style='width:100.0%;
 border-collapse:collapse;border:none;mso-border-alt:solid windowtext .5pt;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr>
  <td width="100%" colspan=3 valign=top style='width:100.0%;border:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></p>
  <p class=MsoEndnoteText><b>Protein: Apolipoprotein A-I</b></p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>D126H</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Damaging</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Detected in individuals from either the top or bottom 2.5<sup>th</sup>
  percentile of a normalized blood pressure distribution (Halushka, et al.
  1999).</p>
  <p class=MsoNormal>??? Role unknown. </p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>K131N</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Tolerated</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>From comparison of ESTs (Garg, et al. 1999) and in an
  electrophoretic screening of newborns. (Von Eckardstein, et al. 1990)</p>
  <p class=MsoNormal>??? Role unknown.</p>
  </td>
 </tr>
 <tr>
  <td width="16%" valign=top style='width:16.3%;border:solid windowtext .5pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>R184P</p>
  </td>
  <td width="16%" valign=top style='width:16.88%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Damaging</p>
  </td>
  <td width="66%" valign=top style='width:66.82%;border-top:none;border-left:
  none;border-bottom:solid windowtext .5pt;border-right:solid windowtext .5pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=MsoNormal>Detected in individuals from either the top or bottom 2.5<sup>th</sup>
  percentile of a normalized blood pressure distribution (Halushka, et al.
  1999).</p>
  <p class=MsoNormal>??? Role unknown.</p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Au, K.G., Zhang, J., Purdy, G.D., Fraser, D.J., Lee, D.,
Noren, N.K,. Cronin, M.T., Chen, J.<span style="mso-spacerun: yes">&nbsp;
</span>(1998) Polymorphism screening of the human peroxisome proliferator
activated receptor <span style='font-family:Symbol'>a</span> gene in diabetic
patients by ABI sequencing and high density oligonucleotide array
technology.<span style="mso-spacerun: yes">&nbsp; </span><i>Am. J. Human Genet.</i><span
style='font-style:normal'> <b>63</b></span>:abs 997 (data on poster, noted by
A.J. Brookes and entered into HGBASE).</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Box N.F., Duff D.L., Irving R.E., Russell, A., Chen, W.,
Griffyths, L.R., Parsons, P.G., Green, A.C., Sturm, R.A. (2001) Melanocortin-1
receptor genotype is a risk factor for basal and squamous cell carcinoma.<span
style="mso-spacerun: yes">&nbsp; </span><i>J Invest. Dermatol</i><span
style='font-style:normal'>. <b>116</b></span>:224-229.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Flavell, D.M., Pineda Torra, I., Jamshidi, Y., Evans, D.
Diamon, J.R., Elkeles, R.S., Bujac, S.R., Miller, G. Talmud, P.J., Staels, B.,
Humphries, S.E.<span style="mso-spacerun: yes">&nbsp; </span>(2000)<span
style="mso-spacerun: yes">&nbsp; </span>Variation in the PPAR<span
style='font-family:Symbol'>a</span> gene is associated with altered function in
vitro and plasma lipid concentrations in Type II diabetic subjects.<span
style="mso-spacerun: yes">&nbsp; </span><i>Diabetologia</i><span
style='font-style:normal'> <b>43</b></span>:673-680.</p>

<p class=MsoEndnoteText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoEndnoteText>Frandberg, P.A., Doufexis, M., Kapas, S., Chhajlani,
V.<span style="mso-spacerun: yes">&nbsp; </span>(1998)<span
style="mso-spacerun: yes">&nbsp; </span>Human pigmentation phenotype: a point
mutation generates nonfunctional MSH receptor.<span style="mso-spacerun:
yes">&nbsp; </span><i>Biochem. Biophys. Res. Commun.</i><span style='font-style:
normal'><span style="mso-spacerun: yes">&nbsp; </span><b>245</b></span>:490-492.</p>

<p class=MsoEndnoteText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Frosst, P., Blom, H.J., Milos, R., Goyette, P. Sheppard,
C.A., Matthews, R.G., Boers, G.J., den Heijer, M., Khuijtmans, L.A., van den
Heuvel, L.P., et al.<span style="mso-spacerun: yes">&nbsp; </span>(1995) A
candidate genetic risk factor for vascular disease: a common mutation in
methylenetetrahydrofolate reductase.<span style="mso-spacerun: yes">&nbsp;
</span><i>Nature Genetics</i><span style='font-style:normal'> <b>10</b></span>:111-113.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Garg, K., Green, P., Nickerson, D.A. (1999) Identification
of candidate coding region single nucleotide polymorphisms in 165 human genes
using assembled expressed sequence tags.<span style="mso-spacerun: yes">&nbsp;
</span><i>Genome Research</i><span style='font-style:normal'> <b>9</b></span>:1087-1092.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Halushka, M.K., Fan, J., Bentley, K., Hsie, L., Shen, N.,
Weder, A., Cooper, R., Lipshutz, R., Chakravarti, A. (1999) Patterns of
single-nucleotide polymorphisms in candidate genes for blood-pressure
homeostatsis.<span style="mso-spacerun: yes">&nbsp; </span><i>Nature Genetics</i><span
style='font-style:normal'> <b>22</b></span>:239-247.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Hara, M., Wang, X., Paz, V.P., Iwasaki, N., Honda, M.,
Iwamoto, Y., Bell, G.I.<span style="mso-spacerun: yes">&nbsp;
</span>(2001)<span style="mso-spacerun: yes">&nbsp; </span>Identification of
three missense mutations in the peroxisome proliferator-activated receptor alpha
gene in Japanese subjects with mature-onset diabetes of the young.<span
style="mso-spacerun: yes">&nbsp; </span><i>J. Hum. Genet.</i><span
style='font-style:normal'> <b>46</b></span>:285-288.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Healy, E. Todd, C., Jackson, I.J., Birch-Machin, M., Rees,
J.L. (1999)<span style="mso-spacerun: yes">&nbsp; </span>Skin type, melanoma,
and melanocortin 1 receptor variants.<span style="mso-spacerun: yes">&nbsp;
</span><i>J. Invest. Dermatol.</i><span style='font-style:normal'> <b>112</b></span>:512-513.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoEndnoteText>Irizarry, K., Kustanovich, V., Li, C. Brown, N.,
Nelson, S. Wong, W., Lee, C.J.<span style="mso-spacerun: yes">&nbsp;
</span>(2000) Genome-wide analysis of single-nucleotide polymorphisms in human
expressed sequences. <i>Nature Genetics</i><span style='font-style:normal'> <b>26</b></span>:233-236.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Lacquemant, C., Lepretre, F., Pineda Torra, I., Manraj, M.,
Charpentier, G., Ruiz, J., Staels, B., Froguel, P.H. (2000) Mutation screening
of the PPAR<span style='font-family:Symbol'>a</span> gene in type 2 diabetes
associated with coronary heart disease.<span style="mso-spacerun: yes">&nbsp;
</span><i>Diabetes &amp; Metabolism</i><span style='font-style:normal'> <b>26</b></span>:393-401.</p>

<p class=MsoEndnoteText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Liu, W., Oefner, P.J., Qian, C., Odom, R.S., Francke,
U.<span style="mso-spacerun: yes">&nbsp; </span>(1997/1998) Denaturing
HPLC-Identified Novel FBN1 Mutations, Polymorphisms, and Sequence Variants in
Marfan Syndrome and Related Connective Tissue Disorder<i>.<span
style="mso-spacerun: yes">&nbsp; </span>Genetic Testing</i><span
style='font-style:normal'> <b>1</b></span>:237-242.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Ma, J., Stampfer, M.J., Giovannucci, E., Artigas, C., Hunter,
D.J., Fuchs, C., Willet, W.C., Selhub, J., Hennekens, C.H., Rozen, R.<span
style="mso-spacerun: yes">&nbsp; </span>(1997) Methylenetetrahydrofolate
reductase polymorphism, dietary interacations, and risk of colorectal cancer.<span
style="mso-spacerun: yes">&nbsp; </span><i>Cancer Research</i><span
style='font-style:normal'> <b>57</b></span>:1098-1102.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Palmer, J.S., Duffy, D.L., Box, N.F., Aitken, J.F.,
O&#8217;Gorman, L.e., Green, A.C., Hayward, N.K., Martin N.G., Sturm, R.A.<span
style="mso-spacerun: yes">&nbsp; </span>(1999)<span style="mso-spacerun:
yes">&nbsp; </span>Melanocortin-1 receptor polymorphisms and risk of melanoma:
is the association explained solely by pigmentation phenotype?<span
style="mso-spacerun: yes">&nbsp; </span><i>Am. J. Hum. Genet.</i><span
style='font-style:normal'> <b>66</b></span>:176-186.</p>

<p class=MsoEndnoteText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Skibola, C.F., Smith, M.T., Kane, E., Roman, E., Rollinson,
S., Cartwright, R.A., Morgan, G.<span style="mso-spacerun: yes">&nbsp;
</span>(1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are
associated with susceptibility to acute leukemia in adults.<span
style="mso-spacerun: yes">&nbsp; </span><i>Proc. Nat. Acad. Sci.</i><span
style='font-style:normal'> <b>96</b></span>:12810-12815.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Valverde, P. Healy, E., Jackson, I., Rees, J.L., Thoday,
A.J.<span style="mso-spacerun: yes">&nbsp; </span>(1995)<span
style="mso-spacerun: yes">&nbsp; </span>Variants of the melanocyte-stimulating
hormone receptor gene are associated with red hair and fair skin in
humans.<span style="mso-spacerun: yes">&nbsp; </span><i>Nature Genetics</i><span
style='font-style:normal'> <b>11</b></span>:328-330.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Valverde, P. Healy, E. Sikkink, S., Haldane, F., Thody,
A.J., Carothers, A., Jackson, I.J., Rees, J.L. (1996)<span style="mso-spacerun:
yes">&nbsp; </span>The Asp84Glu variant of the melanocortin 1 receptor (MC1R)
is associated with melanoma.<span style="mso-spacerun: yes">&nbsp; </span><i>Human
Molecular Genetics</i><span style='font-style:normal'> <b>5</b></span>:1663-1666.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Vohl, M., Lepage, P., Gaudet, D., Brewer, C.G., Betard, C.,
Perron, P., Houde, G., Cellier, c ., Faith, J.M., Despres, J., Morgan, K.,
Hudson, T.J.<span style="mso-spacerun: yes">&nbsp; </span>(2000) <span
style='font-family:"Times New Roman";color:black'>Molecular scanning of the
human PPAR</span><span style='font-family:Symbol;color:black'>a</span><span
style='font-family:"Times New Roman";color:black'> gene: association of the
L162v mutation with hyperapobetalipoproteinemia.<span style="mso-spacerun:
yes">&nbsp; </span><i>J. Lipid Res.</i></span><span style='font-family:"Times New Roman";
color:black'> <b>41</b></span><span style='font-family:"Times New Roman";
color:black'>:945-52.<o:p></o:p></span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>von Eckardstein, A., Funke,H., Walter, M., Altland, K.,
Benninghoven, A., Assmann, G.<span style="mso-spacerun: yes">&nbsp;
</span>(1990) Structural analysis of human apolipoprotein A-I variants.<span
style="mso-spacerun: yes">&nbsp; </span><i>Journal of Biological Chemistry </i><span
style='font-style:normal'><b>265</b></span>:8610-8617.</p>

<p class=MsoEndnoteText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Weisberg, I., Tran, P., Christensen, B., Sibani, S., Rozen,
R.(1998)<span style="mso-spacerun: yes">&nbsp; </span>A second genetic
polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with
decreased enzyme activity.<span style="mso-spacerun: yes">&nbsp; </span><i>Molecular
genetics and metabolism</i><span style='font-style:normal'> <b>64</b></span>:
169-172.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>Wiemels, J.L, Smith, R.N., Taylor, G.M., Eden, O.B.,
Alexander, F.E., Greaves, M.F.,<span style="mso-spacerun: yes">&nbsp; </span>and
United Kingdom Childhood Cancer Study Investigators.<span style="mso-spacerun:
yes">&nbsp; </span>(2001)<span style="mso-spacerun: yes">&nbsp;
</span>Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of
molecularly defined subtypes of childhood acute leukemia.<span
style="mso-spacerun: yes">&nbsp; </span><i>Proc. Nat. Acad. Sci.</i><span
style='font-style:normal'> <b>98</b></span>:4004-4009.</p>

<p class=MsoEndnoteText><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
